DPharm is the founding conference on encouraging collaboration across the industry and creating a medium where start-ups with big ideas can engage with pharma and push our thinking.
New York, New York (PRWEB) July 08, 2015
The Conference Forum has announced the launch of the fifth annual DPharm: Disruptive Innovations to Advance Clinical Trials event to take place September 10-11 at the Boston Park Plaza. Chaired by Craig Lipset, Pfizer, Komathi Stem, Genentech and Dr Andreas Koester, Janssen, the conference is responsible for the latest in innovative thinking to advance clinical trials.
This year, DPharm kicks off with a keynote patient speaker who sings opera with someone else’s lungs. This is followed by a keynote panel on creating a culture of sustainable innovation with Harvest Power, one of Fast Company’s top-rated innovative companies. Joining Harvest Power is MIT to present the academic view, and from industry, an HR head from Janssen and a senior director on innovation and strategy from Bayer AG. The conference continues with new research platforms from Johnson & Johnson, the latest on the Apple Research Kit for clinical trials, a brand new case study from Scripps Clinic on using mhealth in a real world setting, and sessions from Genentech, AbbVie and Eli Lilly on the future of clinical trials.
“DPharm is the founding conference on encouraging collaboration across the industry and creating a medium where start-ups with big ideas can engage with pharma and push our thinking,” said Komathi Stem, Strategic Innovation Leader, Genentech/Roche.
The conference will challenge the big elephant in the room: how to disrupt the CRO industry. It addresses the “walking dead” with EDC, clinical trial operations and the mobile phone. The conference also includes a White House representative to provide an update on the Precision Medicine Initiative. Google[x] and IBM Watson share their latest technology for clinical trials, while a number of other tech companies have booths in the exhibit rooms.
Cures Within Reach presents for the first time at DPharm on its process to accelerate cures through repurposing research and Allergan shares a performance excellence model in drug development.
“This is the most innovative time in clinical research with the greatest progress in collaborative partnerships. We are proud to present the conference gathering for clinical trial innovation,” said Valerie Bowling, DPharm Director
The History of DPharm
The first DPharm conference started with content addressing virtual clinical trial models, adaptive design thinking, the role of EHRs in clinical data, open source, telemedicine, and self-reported patient data among many other ideas. By the time the 2nd annual DPharm program took place, the concept of applying disruptive thinking to clinical development had taken root, with many attendees bearing titles with clinical innovation in them. Fast forward to 2015, the fifth annual program brings more examples of innovation and collaboration than ever before in the advancement of clinical trials.
About the Conference Forum
The Conference Forum develops specialized events for professionals in the life science and healthcare industries. We currently offer conferences for R&D leaders, clinical development professionals, biotech executives, VCs, drug delivery specialists and pharma/generic government directors. Our mission is to create the best content, exchange ideas and solutions among peers and provide quality networking for Pharmaceutical and Biotech professionals. http://www.theconferenceforum.org